RT Journal Article
SR Electronic
T1 Interferon alpha-induced non-immune thyrotoxicosis treated by plasmapheresis
JF BMJ Case Reports
FD BMJ Publishing Group Ltd
SP bcr-2017-221228
DO 10.1136/bcr-2017-221228
VO 2017
A1 Zeynel Abidin Sayiner
A1 Ayten Eraydın
A1 Taylan Metin
A1 Mesut Özkaya
YR 2017
UL http://casereports.bmj.com/content/2017/bcr-2017-221228.abstract
AB Interferon-alpha (IFN-α) is an effective drug used for the treatment of chronic hepatitis C. So far its numerous side effects have been reported in the literature. It may be difficult to always put IFN-induced thyroid diseases into a single classic thyroid disease table. There are numerous atypical thyroid diseases due to IFN usage for hepatitis C virus. Herein, we present a case with a rare clinical table such as thyrotoxicosis observed following IFN-α therapy in a patient with euthyroid nodular thyroid without autoimmune thyroiditis findings and the use of therapeutic apheresis method for the treatment of disease.